Prognostic significance of pre-S2 antigen and antibody in fulminant hepatitis B. Evidence for heterogeneous serological responses

J Hepatol. 1991 Jul;13(1):49-55. doi: 10.1016/0168-8278(91)90863-7.

Abstract

Serial sera were collected prospectively and from early on in the clinical course of ten patients with fulminant hepatitis B. These were analysed for HBV DNA (dot-blot technique), HBsAg, HBeAg, pre-S2-Ag and their respective antibodies. Two patterns emerged in nine of the patients. The first and well-recognised pattern of rapid clearance of antigens and appearance of antibodies was seen in four patients, all of whom survived. The second pattern seen in five patients was one of persistence of HBsAg and pre-S2 antigen and failure to detect antibodies but only one patient survived. The first pattern may reflect a more rapid cessation of virus replication and this may favour liver cell regeneration and recovery. In contrast, the second pattern may indicate continuing virus replication and liver cell damage which could contribute to the high mortality in some patients with fulminant hepatitis B.

MeSH terms

  • Adolescent
  • Adult
  • DNA, Viral / genetics
  • Female
  • Hepatitis B / blood*
  • Hepatitis B / immunology
  • Hepatitis B / mortality
  • Hepatitis B Antibodies / analysis*
  • Hepatitis B Antibodies / immunology
  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis B e Antigens / analysis
  • Hepatitis B e Antigens / immunology
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Protein Precursors / analysis*
  • Protein Precursors / immunology
  • Viral Envelope Proteins / analysis
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology

Substances

  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Protein Precursors
  • Viral Envelope Proteins
  • presurface protein 2, hepatitis B surface antigen